Podchaser Logo
Home
FierceBiotech RadioEpisode from the podcastFierceBiotech Radio
Next Episode
Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand

Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand

Released Thursday, 15th October 2015
Good episode? Give it some love!
Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand

Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand

Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand

Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand

Thursday, 15th October 2015
Good episode? Give it some love!
Rate Episode
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript

Fierce editors discuss a major blow to Eli Lilly's late-stage pipeline, Mylan's ongoing courtship of Perrigo, and Merck KGaA's big push to distance itself from that other Merck.

Show More
Rate
Get this podcast via API

From The Podcast

FierceBiotech Radio

FierceBiotech brings you interviews and analysis from around the biotech, pharma and medical device industries.

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More